On December 27, 2020, the President signed the Consolidated Appropriations Act, 2021
(CAA 2021), which includes Medicare enrollment changes. Section 402, Extended Months
of Coverage of Immunosuppressive Drugs for Kidney Transplant Patients and Other Renal
Dialysis Provisions, which allows a person who has no other certain health insurance
coverage to enroll in drug coverage under Medicare Part B (Part B-ID) (see HI 00805.400D for list of excluded health coverages). Enrollment in Medicare Parts A and B for
people who have End-Stage Renal Disease (ESRD) generally ends 36 months after a successful
kidney transplant. This new provision allows Part B-ID coverage, solely for immunosuppressive
drugs, to extend beyond the original 36 months. This extended coverage may start as
early as January 1, 2023, or the month following the month in which the signed application
and attestation is submitted.
Beneficiaries enrolled in Part B-ID will not be covered for any other Medicare benefit(s)
or for any items or services other than Part B-ID.